Prospective Study
Copyright ©The Author(s) 2017.
World J Hepatol. Jul 8, 2017; 9(19): 857-866
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.857
Table 1 General and echocardiographic characteristics of the study population with and without hepatic steatosis at baseline n (%)
No/one criterion for hepatic steatosisUS+ and ALT+P-value
n = 1106n = 192
Age (yr), M (SD)59.6 (8.8)57.2 (7.8)P < 0.01
Male gender442 (40.0)139 (72.4)P < 0.001
School educationn.s.
< 10 yr570 (51.5)102 (53.1)
10 yr358 (32.4)67 (34.9)
> 10 yr178 (16.1)23 (12.0)
Waist circumference (cm), M (SD)89.0 (11.5)100.8 (10.9)P < 0.001
Body weight (kg), M (SD)75.6 (12.8)88.6 (13.9)P < 0.001
BMI, (kg/m2), M (SD)27.4 (4.3)30.5 (4.6)P < 0.001
SmokingP < 0.001
Never-smoker516 (46.6)57 (29.7)
Ex-smoker382 (34.5)99 (51.7)
Current smoker208 (18.8)36 (18.8)
Alcohol consumption (g/d), M (SD)9.1 (14.5)15.6 (19.5)P < 0.001
Diabetes mellitus100 (9.0)26 (13.5)P < 0.001
Systolic blood pressure (mmHg), M (SD)139.3 (20.2)148.5 (17.4)P < 0.001
Diastolic blood pressure (mmHg), M (SD)84.7 (10.8)89.9 (10.4)P < 0.001
Pulse pressure (mmHg), M (SD)54.6 (14.7)58.6 (13.4)P < 0.01
Hypertension660 (59.7)163 (84.9)P < 0.001
Intake of drugs with ATC07239 (21.6)39 (20.3)n.s.
Intake of drugs with ATC08140 (12.7)28 (14.6)n.s.
Intake of drugs with ATC09198 (17.9)58 (30.2)P < 0.001
IVS, M (SD)9.7 (2.2)10.9 (2.5)P < 0.001
LVEDD, M (SD)50.9 (5.6)52.4 (5.9)P < 0.01
PWD, M (SD)9.6 (1.9)10.4 (2.0)P < 0.001
LVM (g), M (SD)181.8 (53.5)215.8 (61.3)P < 0.001
LVMI (g/m2.7), M (SD)46.2 (13.3)51.0 (13.7)P < 0.001
LVH499 (45.1)114 (59.4)P < 0.001